MA45855A - Nouvelle utilisation du n, n-bis-2-mercaptoéthyle isophtalamide - Google Patents

Nouvelle utilisation du n, n-bis-2-mercaptoéthyle isophtalamide

Info

Publication number
MA45855A
MA45855A MA045855A MA45855A MA45855A MA 45855 A MA45855 A MA 45855A MA 045855 A MA045855 A MA 045855A MA 45855 A MA45855 A MA 45855A MA 45855 A MA45855 A MA 45855A
Authority
MA
Morocco
Prior art keywords
isophtalamide
mercaptoethyl
bis
new use
new
Prior art date
Application number
MA045855A
Other languages
English (en)
Other versions
MA45855B1 (fr
Inventor
Boyd Eugene Haley
Ragnar Axel Theodor Klingberg
Original Assignee
Emeramed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emeramed Ltd filed Critical Emeramed Ltd
Publication of MA45855A publication Critical patent/MA45855A/fr
Publication of MA45855B1 publication Critical patent/MA45855B1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA45855A 2016-08-05 2017-08-04 Nouvelle utilisation du n, n-bis-2-mercaptoéthyle isophtalamide MA45855B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201613535 2016-08-05
PCT/GB2017/052306 WO2018025049A1 (fr) 2016-08-05 2017-08-04 Nouvelle utilisation du n,n-bis-2-mercaptoéthyl-isophtalamide

Publications (2)

Publication Number Publication Date
MA45855A true MA45855A (fr) 2021-03-17
MA45855B1 MA45855B1 (fr) 2022-02-28

Family

ID=60202272

Family Applications (1)

Application Number Title Priority Date Filing Date
MA45855A MA45855B1 (fr) 2016-08-05 2017-08-04 Nouvelle utilisation du n, n-bis-2-mercaptoéthyle isophtalamide

Country Status (30)

Country Link
US (2) US20190240173A1 (fr)
EP (2) EP4029497A1 (fr)
JP (1) JP6926192B2 (fr)
KR (1) KR102538388B1 (fr)
CN (2) CN121926911A (fr)
AU (1) AU2017305661B2 (fr)
BR (1) BR112019002130A2 (fr)
CL (1) CL2019000229A1 (fr)
CY (1) CY1125039T1 (fr)
DK (1) DK3493849T3 (fr)
EA (1) EA201990443A1 (fr)
ES (1) ES2907838T3 (fr)
HR (1) HRP20220252T1 (fr)
HU (1) HUE057782T2 (fr)
IL (1) IL264538B2 (fr)
LT (1) LT3493849T (fr)
MA (1) MA45855B1 (fr)
MD (1) MD3493849T2 (fr)
MX (1) MX387853B (fr)
MY (1) MY199733A (fr)
PH (1) PH12019500237A1 (fr)
PL (1) PL3493849T3 (fr)
PT (1) PT3493849T (fr)
RS (1) RS62924B1 (fr)
SG (1) SG11201900565RA (fr)
SI (1) SI3493849T1 (fr)
SM (1) SMT202200109T1 (fr)
UA (1) UA125394C2 (fr)
WO (1) WO2018025049A1 (fr)
ZA (1) ZA201900594B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202005057D0 (en) 2020-04-06 2020-05-20 Emeramed Ltd New Use
WO2026037909A1 (fr) * 2024-08-16 2026-02-19 Emeramed Limited N,n-bis-2-mercaptoéthyl isophtalamide destiné à être utilisé dans le traitement de la douleur

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586600B2 (en) 2000-12-06 2003-07-01 University Of Kentucky Research Foundation Multidentate sulfur-containing ligands
US8950583B2 (en) * 2008-12-06 2015-02-10 Ermes Medical Company Limited Method to remove heavy metals from a mammal
US20120122787A1 (en) * 2009-07-10 2012-05-17 Rong Li Methods for treating polycystic kidney disease (pkd) or other cyst forming diseases
CA2775397A1 (fr) 2009-09-28 2011-03-31 University Of Kentucky Research Foundation Composes contenant un thiol pour l'elimination d'elements de milieux contamines et procedes d'utilisation associes
US8575218B2 (en) 2009-09-28 2013-11-05 The University Of Kentucky Research Foundation Thiol-containing compounds for the removal of elements from tissues and formulations therefor
US20110237776A1 (en) 2010-03-25 2011-09-29 Haley Boyd E Aromatic compounds with sulfur containing ligands
US8426368B2 (en) 2010-03-25 2013-04-23 The University Of Kentucky Research Foundation Method of ameliorating oxidative stress and supplementing the diet

Also Published As

Publication number Publication date
SG11201900565RA (en) 2019-02-27
US20250325503A1 (en) 2025-10-23
PH12019500237A1 (en) 2019-10-28
JP6926192B2 (ja) 2021-08-25
RS62924B1 (sr) 2022-03-31
UA125394C2 (uk) 2022-03-02
ZA201900594B (en) 2019-08-28
SI3493849T1 (sl) 2022-04-29
CN109562179A (zh) 2019-04-02
MY199733A (en) 2023-11-21
BR112019002130A2 (pt) 2019-05-14
EP3493849A1 (fr) 2019-06-12
LT3493849T (lt) 2022-03-10
MD3493849T2 (ro) 2022-04-30
DK3493849T3 (en) 2022-03-07
IL264538A (fr) 2019-03-31
MX387853B (es) 2025-03-19
IL264538B2 (en) 2023-02-01
ES2907838T3 (es) 2022-04-26
NZ750271A (en) 2025-07-25
CL2019000229A1 (es) 2019-04-26
SMT202200109T1 (it) 2022-05-12
KR20190035724A (ko) 2019-04-03
US20190240173A1 (en) 2019-08-08
MA45855B1 (fr) 2022-02-28
IL264538B (en) 2022-10-01
KR102538388B1 (ko) 2023-05-30
EP3493849B1 (fr) 2021-12-01
EA201990443A1 (ru) 2019-07-31
PT3493849T (pt) 2022-02-23
AU2017305661B2 (en) 2023-05-18
EP4029497A1 (fr) 2022-07-20
AU2017305661A1 (en) 2019-02-14
PL3493849T3 (pl) 2022-03-28
HUE057782T2 (hu) 2022-06-28
WO2018025049A1 (fr) 2018-02-08
CY1125039T1 (el) 2023-03-24
HRP20220252T1 (hr) 2022-04-29
MX2019000978A (es) 2019-06-10
CA3032858A1 (fr) 2018-02-08
CN121926911A (zh) 2026-04-28
JP2019524782A (ja) 2019-09-05

Similar Documents

Publication Publication Date Title
EP3389630A4 (fr) Identification de néogènes, fabrication et utilisation
EP3420396A4 (fr) Élargissement de pupille
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
LT3105226T (lt) Ciklopropilaminai, kaip lsd1 inhibitoriai
DK3348556T3 (da) Heteroarylamider som hæmmere af proteinaggregering
DK3072952T3 (da) Anvendelse af en ny køleolie
DK3256462T3 (da) Substituerede 2-thioimidazolyl-carboxamider som skadedyrsbekæmpelsesmiddel
IL263050B (en) Derivatives of sobetirome
EP3541724A4 (fr) Gestion optimisée de commandes autre que par vagues
EP3399032A4 (fr) Nouvelle bêta-galactosidase
PL3400269T3 (pl) Zastosowanie 4-bora-3a,4a-diaza-s-indacenów do zabezpieczania
DK3298022T3 (da) Nye annelerede phenoxyacetamider
EP3378611A4 (fr) Rasoir
DK3328395T3 (da) Ny brug af dextransulfat
EP3550018A4 (fr) NOUVELLE ENDO-ß-N-ACÉTYLGLUCOSAMINIDASE
EP3520789A4 (fr) Nouvelle utilisation de l'amlexanox
EP3721889A4 (fr) Utilisation debutyribacter intestini
EP3623755A4 (fr) Règle
MA45855A (fr) Nouvelle utilisation du n, n-bis-2-mercaptoéthyle isophtalamide
ME03734B (fr) Combinaison
EP3357349A4 (fr) Nouilles sautées instantanées
HUE036206T2 (hu) N,N-bisz-2-merkaptoetil-izoftálamid új alkalmazása
EP3727126A4 (fr) Scope à usages multiples
EP3338775A4 (fr) Utilisation de butylidène-phthalide
EP3329121C0 (fr) Pont